On Tuesday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) opened higher 3.74% from the last session, before settling in for the closing price of $14.69. Price fluctuations for PHAT have ranged from $2.21 to $16.45 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 12.50%. Company’s average yearly earnings per share was noted 40.26% at the time writing. With a float of $41.36 million, this company’s outstanding shares have now reached $71.04 million.
Phathom Pharmaceuticals Inc (PHAT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Phathom Pharmaceuticals Inc is 41.86%, while institutional ownership is 50.71%. The most recent insider transaction that took place on Nov 03 ’25, was worth 7,079. In this transaction Principal Accounting Officer of this company sold 524 shares at a rate of $13.51, taking the stock ownership to the 47,407 shares. Before that another transaction happened on Sep 05 ’25, when Company’s Principal Accounting Officer sold 461 for $12.09, making the entire transaction worth $5,573. This insider now owns 47,931 shares in total.
Phathom Pharmaceuticals Inc (PHAT) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -1.05 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.08) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.26% per share during the next fiscal year.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Trading Performance Indicators
Check out the current performance indicators for Phathom Pharmaceuticals Inc (PHAT). In the past quarter, the stock posted a quick ratio of 2.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.81, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -0.60 in one year’s time.
Technical Analysis of Phathom Pharmaceuticals Inc (PHAT)
The latest stats from [Phathom Pharmaceuticals Inc, PHAT] show that its last 5-days average volume of 0.75 million was inferior to 1.53 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 30.47%.
During the past 100 days, Phathom Pharmaceuticals Inc’s (PHAT) raw stochastic average was set at 85.64%, which indicates a significant increase from 48.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.76 in the past 14 days, which was lower than the 0.82 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.92, while its 200-day Moving Average is $9.30. Now, the first resistance to watch is $15.58. This is followed by the second major resistance level at $15.93. The third major resistance level sits at $16.45. If the price goes on to break the first support level at $14.71, it is likely to go to the next support level at $14.19. Assuming the price breaks the second support level, the third support level stands at $13.84.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Key Stats
There are currently 71,138K shares outstanding in the company with a market cap of 1.08 billion. Presently, the company’s annual sales total 55,250 K according to its annual income of -334,330 K. Last quarter, the company’s sales amounted to 49,500 K and its income totaled -29,970 K.
